SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 30, 2000
ALFACELL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-11088 22-2369085
(State or other jurisdiction (Commission file Number) (IRS Identification No.)
of incorporation)
225 Belleville Avenue, Bloomfield, New Jersey 07003
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (973) 748-8082
(Former name or former address, if changed since last report)
<PAGE>
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
Exhibit No. Description
----------- -----------
99.1 Letter to Shareholders of Alfacell Corporation, dated
November 30, 2000.
Item 9. Regulation FD Disclosure
The letter attached as Exhibit 99.1 hereto is furnished pursuant to Regulation
FD; it is not filed.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: November 30, 2000
ALFACELL CORPORATION
(Registrant)
By: /s/ Kuslima Shogen
-----------------------------------
Kuslima Shogen
Chief Executive Officer
